A systematic review conducted by Sciascia et al. described a detailed analysis of the relationship between aPS/aPT and thrombotic events and concluded that the presence of aPS/aPT antibodies does increase the risk of arterial thrombosis [117]. The gene discussed is LYPLA2P1; the disease is Arterial thrombosis.